Occurrence of Skeletal-Related Events in Multiple Myeloma and Prostate Cancer Patients Receiving Standard Versus Extended-Interval Zoledronic Acid September 12, 2018Multiple MyelomaProstate CancerHematologic Malignancies
Fracture risk linked to mortality in women with myelomaAugust 29, 2018Multiple MyelomaHematologic Malignancies
Treatment simulation could help personalize myeloma therapyJuly 31, 2018Multiple MyelomaHematologic Malignancies
Myeloma frailty index predicts survival based on biological ageJuly 25, 2018Multiple MyelomaHematologic Malignancies
Promising phase 3 results for ixazomib in multiple myelomaJuly 13, 2018Multiple MyelomaHematologic Malignancies
Ruxolitinib overcame lenalidomide resistance in myelomaJune 3, 2018Multiple MyelomaHematologic Malignancies
CAR T therapy to enter early testing in multiple myelomaMay 30, 2018Multiple MyelomaHematologic Malignancies
More evidence links increased BMI to higher multiple myeloma riskMarch 17, 2018Multiple MyelomaHematologic Malignancies
Treatment and Management of Multiple Myeloma (FULL)February 17, 2018OncologyMultiple MyelomaHematologic Malignancies
Meningococcal Arthritis Masking as Possible MyelomaFebruary 8, 2018Multiple MyelomaHematologic Malignancies
Continue to opt for HDT/ASCT for multiple myelomaJanuary 5, 2018Multiple MyelomaHematologic Malignancies
Late-breaking abstracts highlight treatment advances in CLL, myeloma, and moreNovember 22, 2017Hematologic MalignanciesMultiple Myeloma
